Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
The Pediatric Infectious Disease Journal
|
August 14, 2019
Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort
Sanjay Jayasinghe, Bette Liu, Heather Gidding, et al.
Journal of Clinical Nursing
|
May 5, 2011
Decisions about transferring nursing home residents to hospital: highlighting the roles of advance care planning and support from local hospital and community health services
Christopher Shanley, Elizabeth Whitmore, David Conforti, et al.
The Lancet. Infectious Diseases
|
March 27, 2012
Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study
Melina Georgousakis, Sanjay Jayasinghe, Julia Brotherton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 23, 2018
Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study
Sanjay Jayasinghe, Clayton Chiu, Helen Quinn, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
October 18, 2018
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Cyra Patel, Julia Ml Brotherton, Alexis Pillsbury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014
Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2024
Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study
Sanjay Jayasinghe, Phoebe C M Williams, Kristine K Macartney, et al.
Communicable Diseases Intelligence Quarterly Report
|
January 14, 2014
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010
Latika Naidu, Clayton Chiu, Andrew Habig, et al.
Vaccine
|
November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Sanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage Study
Alamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
The Pediatric Infectious Disease Journal
|
August 14, 2019
Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort
Sanjay Jayasinghe, Bette Liu, Heather Gidding, et al.
Journal of Clinical Nursing
|
May 5, 2011
Decisions about transferring nursing home residents to hospital: highlighting the roles of advance care planning and support from local hospital and community health services
Christopher Shanley, Elizabeth Whitmore, David Conforti, et al.
The Lancet. Infectious Diseases
|
March 27, 2012
Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study
Melina Georgousakis, Sanjay Jayasinghe, Julia Brotherton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 23, 2018
Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study
Sanjay Jayasinghe, Clayton Chiu, Helen Quinn, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
October 18, 2018
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Cyra Patel, Julia Ml Brotherton, Alexis Pillsbury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014
Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2024
Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study
Sanjay Jayasinghe, Phoebe C M Williams, Kristine K Macartney, et al.
Communicable Diseases Intelligence Quarterly Report
|
January 14, 2014
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010
Latika Naidu, Clayton Chiu, Andrew Habig, et al.
Vaccine
|
November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Sanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage Study
Alamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Page
of 5